Published source snapshot
NooRacetam 800
LifeLink · US label facts
Label IDlbl_dsld_11847_e637e018b43ec267
Serving size1 Capsule(s)
Serving formCapsule(s)
Retrieved
Scope: source-market status describes the source record, not live availability. Quantities below are label facts and deterministic arithmetic, not a product recommendation.
Original facts and normalized results
| Ingredient | Original label quantity | Requested normalization | Measurement object |
|---|---|---|---|
| Piracetam DSLD row path: root.0; DSLD ingredientId: 47209 | 800 mg | 800 mg / as_labeled | Piracetam |
| Cellulose Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 4734. | Not stated | missing_quantity | Microcrystalline Cellulose |
Label statements
These are explicitly classified as label claims. They are not converted into platform-endorsed scientific conclusions.
- label_claim General Statements: All Other Content: NooRacetam is a formulation of piracetam, a nutraceutical that has broad positive effects on brain function and blood characteristics. It appears to work by altering the fluidity of cellular membranes. See our website for details: www.lifelinknet.com/siteResources/Products/NooRacetam.asp
- label_claim Suggested/Recommended/Usage/Directions: Suggested Use: 1-4 capsules 3 times a day or as directed by a health care professional.
- label_claim General Statements: All Other Content: - a piracetam nutraceutical -
- label_claim FDA Statement of Identity: DIETARY SUPPLEMENTS
Ingredient references
Reference pages provide verified source mappings. Unless a real review record exists, they remain reference-only with no medical summary or evidence grade.
Source and version
- Original record
- NIH ODS DSLD label 11847
- Local snapshot
- snap_dsld_11847_e637e018b43ec26737080f2a
- Content hash
e637e018b43ec26737080f2a8b39c01586f17b9190d7422bf58f83da21654511- Source version
- Not stated
Limitations
- This record reports label facts from a US-market source snapshot, not current inventory or product safety.
- Label quantity comparisons do not establish absorption, efficacy, safety, or clinical equivalence.